K
v
ire
.com
←
Back
Night
Docs
Library
Review
…
Author
Ronald Levy
also known as Astrid Eckert, Levy, R., Levy, Raphael
Hôpital Necker-Enfants Malades · Université Claude Bernard Lyon 1 · Northwestern University · James S. McDonnell Foundation
About this author
Works
956
Cited by
71,654
h-index
124
i10
439
ORCID ↗
Top papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Ash A. Alizadeh, Michael B. Eisen, R. Eric Davis, et al.
·
2000
·
Nature
↗ 9,925
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett, et al.
·
2017
·
New England Journal of Medicine
↗ 5,818
OA
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
Peter McLaughlin, A.J. Grillo-López, Brian K. Link, et al.
·
1998
·
Journal of Clinical Oncology
↗ 2,755
Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells
Frank J. Hsu, Claudia Benike, Francesco Fagnoni, et al.
·
1996
·
Nature Medicine
↗ 1,837
OA
IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma
David G. Maloney, Antonio J Grillo-López, Christine A. White, et al.
·
1997
·
Blood
↗ 1,694
Two Immunoglobulin G Fragment C Receptor Polymorphisms Independently Predict Response to Rituximab in Patients With Follicular Lymphoma
Wen‐Kai Weng, Ronald Levy
·
2003
·
Journal of Clinical Oncology
↗ 1,287
Two populations of Ia-like molecules on a human B cell line.
L A Lampson, Ronald Levy
·
1980
·
The Journal of Immunology
↗ 1,102
Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
Mark P. Chao, Ash A. Alizadeh, Chad Tang, et al.
·
2010
·
Cell
↗ 1,071
OA
Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype Antibody
Richard Miller, David G. Maloney, Roger A. Warnke, et al.
·
1982
·
New England Journal of Medicine
↗ 990
Prediction of Survival in Diffuse Large-B-Cell Lymphoma Based on the Expression of Six Genes
Izidore S. Lossos, Debra K. Czerwinski, Ash A. Alizadeh, et al.
·
2004
·
New England Journal of Medicine
↗ 935
Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma
DG Maloney, TM Liles, DK Czerwinski, et al.
·
1994
·
Blood
↗ 750
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia
Jonathan W. Friedberg, Jeff P. Sharman, John Sweetenham, et al.
·
2009
·
Blood
↗ 736
OA